Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11309 |
FMF-04-159-2
|
CDK | Cell Cycle/Checkpoint |
FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively. FMF-04-159-2 is a covalent CDK14 inhibitor. | |||
T36305 |
FMF-04-159-R
|
||
Potent inhibitor of CDK16 and CDK14 (IC50 values are 6 and 140 nM, respectively in kinase activity assay; IC50 = 563 nM for CDK14 in BRET assay). Also binds CDK2 (IC50 = 493 nM). Inhibition reversible upon compound wash-out. Control for FMF-04-159-2 (Cat. No. 7158). |